Sort
48,018 grants matching “immunotherapy”
Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment
$379,343Ling Gao · Southern California Inst For Res/Educ · R01 · FY2023 · CA
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$379,337Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform
$379,335Tania Tali Konry · Northeastern University · R33 · FY2020 · CA
Screening and implementing universal ligands for immunoglobulins
$379,313Valeria T Milam · Georgia Tech Research Corporation · · FY2018 · ENG
Augmentation of Immune Response to Head & Neck Squamous Cell Carcinoma via Phosp
$379,298Ivan M Borrello · Johns Hopkins University · P50 · FY2013 · DE
Optimizing CAR T Cell Therapy
$379,293Bruce R. Blazar · University Of Minnesota · P01 · FY2016 · CA
Cell Therapy Core
$379,270Victor M Lemas · Johns Hopkins University · P01 · FY2019 · CA
Type I Interferon Pathway in Pancreatic Adenocarcinoma
$379,268Serge Y Fuchs · University Of Pennsylvania · R01 · FY2020 · CA
Breaking Tolerance to Induce Tumor-Specific Cytotoxic CD4 Th1 Cells
$379,260Adam J Adler · University Of Connecticut Sch Of Med/Dnt · R01 · FY2015 · AI
Optimizing CAR T Cell Therapy
$379,257Bruce R. Blazar · University Of Minnesota · P01 · FY2017 · CA
SPORE in Lung Cancer
$379,250Jill M Siegfried · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
A Novel Symbiotic Approach for Ovarian Cancer
$379,248Jogender Tushir-Singh · University Of California At Davis · R01 · FY2022 · CA
Hypoxia-Perfusion Bioreactor for Stem Cell Applications
$379,228Todd A McAdams · Resodyn Corporation · R44 · FY2009 · HL
Optimizing CAR T Cell Therapy
$379,224Bruce R. Blazar · University Of Minnesota · P01 · FY2018 · CA
Role of KAT5 in lung cancer
$379,196Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Cellular Immunity/JC Virus/AIDS/Leukoencephalopathy
$379,170Igor J Koralnik · Beth Israel Deaconess Medical Center · R01 · FY2006 · NS
Regulation of gamma delta T cell immunoediting by novel phosphoantigens
$379,166Andrew J Wiemer · University Of Connecticut Storrs · R01 · FY2015 · CA
Dyslipidemia and Diabetic Retinopathy
$379,150Julia V Busik · Michigan State University · R01 · FY2022 · EY
PET fibrin imaging of DVT and PE
$379,125Tilo Winkler · Massachusetts General Hospital · R01 · FY2019 · HL
PET fibrin imaging of DVT and PE
$379,125Tilo Winkler · Massachusetts General Hospital · R01 · FY2020 · HL
PET fibrin imaging of DVT and PE
$379,125Tilo Winkler · Massachusetts General Hospital · R01 · FY2021 · HL
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$379,104Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Breaking Tolerance to Induce Tumor-Specific Cytotoxic CD4 Th1 Cells
$379,088Adam J Adler · University Of Connecticut Sch Of Med/Dnt · R01 · FY2016 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$379,055Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · AI
The B7x pathways in the tumor microenvironment
$379,050Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA